<DOC>
	<DOCNO>NCT00740324</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy additional administration scopolamine butylbromide , glucagon NPO-11 follow single intragastric dose NPO-11 endoscopy healthy adult men . The safety evaluate base adverse event adverse drug reaction ( ADRs ) observe NPO-11 + scopolamine butylbromide glucagon , follow additional administration NPO-11 . The efficacy evaluate base change frequency gastric peristalsis classification initial dose additional dose , presence absence gastric peristalsis evaluation point .</brief_summary>
	<brief_title>Exploratory Study Additional Use Scopolamine Butylbromide , Glucagon NPO-11 Following Single Dose NPO-11 Healthy Adult Men</brief_title>
	<detailed_description />
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Healthy adult male volunteer meet follow criterion enrol study . Subjects provide write informed consent voluntary participation study . 1 . Volunteers good health confirm investigator subinvestigator 2 . Volunteers ( age 35 less 65 year old time consent ) Volunteers meet follow criterion exclude study . 1 . Volunteers clinically significant symptom , physical finding laboratory value screen visit consider unsuitable participation study investigator 's subinvestigator 's opinion 2 . Volunteers history surgery upper gastrointestinal tract 3 . Volunteers history shock hypersensitivity lmenthol peppermint oil ( mint oil ) 4 . Volunteers history shock hypersensitivity scopolamine butylbromide , glucagon , lidocaine hydrochloride heparin sodium 5 . Volunteers contraindicate administration scopolamine butylbromide glucagon investigator 's subinvestigator 's opinion base health interview 6 . Volunteers expose NPO11 7 . Volunteers receive investigational drug within four month consent participate clinical study 8 . Volunteers otherwise ineligible participation study investigator 's subinvestigator 's opinion</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>During</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Gastric</keyword>
	<keyword>Peristalsis</keyword>
</DOC>